Pfizer Inc. (NEO:PFE)

Market Cap	192.14B
Revenue (ttm)	87.17B
Net Income (ttm)	14.68B
Shares Out	n/a
EPS (ttm)	2.59
PE Ratio	13.09
Forward PE	8.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,152
Average Volume	77,434
Open	11.13
Previous Close	11.09
Day's Range	11.05 - 11.23
52-Week Range	9.68 - 14.16
Beta	0.44
RSI	51.05
Earnings Date	Aug 5, 2025

About Instructure Holdings

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.